Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Acta Radiologica: Therapy, Physics, Biology|December 1, 1976
Anti-oestrogen therapy of advanced mammary carcinomaH Westerberg, B Nordenskjöld, A de Schryver, et al.
European Journal of Haematology|June 8, 1999
Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratiosK Carlson, A Larsson, B Simonsson, et al.
Blood|February 3, 1998
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study GroupC Seidel, M Børset, I Turesson, et al.
European Journal of Haematology|May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)M Hjorth, E Holmberg, S Rödjer, et al.
British Journal of Haematology|June 10, 2000
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myelomaG Juliusson, F Celsing, I Turesson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Low-dose hypersensitivity: current status and possible mechanismsM C Joiner, B Marples, P Lambin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish studyJ Westin, A Cortelezzi, M Hjorth, et al.
International Journal of Cancer|December 8, 1998
Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation TherapyN G Burnet, J Johansen, I Turesson, et al.
British Journal of Haematology|March 1, 1995
Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study GroupJ Westin, S Rödjer, I Turesson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patternsI Turesson, N Sandberg, C Mercke, et al.
Pageof 13